1993
DOI: 10.1021/ja00056a047
|View full text |Cite
|
Sign up to set email alerts
|

Polymerized liposomes containing C-glycosides of sialic acid: potent inhibitors of influenza virus in vitro infectivity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
112
0
3

Year Published

1996
1996
2015
2015

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 184 publications
(117 citation statements)
references
References 1 publication
2
112
0
3
Order By: Relevance
“…Liposomes are particularly attractive scaffolds for designing polyvalent inhibitors [9,10,[12][13][14][15]; however, the poor colloidal stability of conventional liposomes and their short circulation times in vivo [16,17] are major obstacles limiting their therapeutic use. We describe the design of highly stable and active polyvalent anthrax toxin inhibitors based on liposomes incorporating polyethylene glycol (PEG)-functionalized lipids (PEGylated liposomes).…”
mentioning
confidence: 99%
“…Liposomes are particularly attractive scaffolds for designing polyvalent inhibitors [9,10,[12][13][14][15]; however, the poor colloidal stability of conventional liposomes and their short circulation times in vivo [16,17] are major obstacles limiting their therapeutic use. We describe the design of highly stable and active polyvalent anthrax toxin inhibitors based on liposomes incorporating polyethylene glycol (PEG)-functionalized lipids (PEGylated liposomes).…”
mentioning
confidence: 99%
“…These conjugates have been useful for both site-directed drug delivery [22] and for studies of water-monolayer surface interactions [23]. Calixarenes are efficient sodium ionophores and are applied as such in chemical sensors.…”
Section: Calixarenesmentioning
confidence: 99%
“…Na Figura 13 encontram-se apresentadas as interações importantes entre o sítio ativo da hemaglutinina do vírus influenza e o receptor sialosídeo da molécula hospedeira. Porém, o sítio ativo da hemaglutinina apresenta uma afinidade fraca por sialosídeos monoméricos (com apenas um resíduo de ácido siálico), o que difi- culta o desenvolvimento de sialilmiméticos que atuem de forma eficiente sobre a hemaglutinina [40][41][42] 18 , que foi sintetizada e avaliada quanto à atividade inibitória da hemaglutinina [43][44][45][46] 14). No entanto, há necessidade de estratégias sintéticas mais elaboradas para a obtenção de sialilmiméticos poliméricos 16 .…”
Section: Desenhando Fármacos Antiinfluenzaunclassified